1997
DOI: 10.3109/08860229709026261
|View full text |Cite
|
Sign up to set email alerts
|

Incidence of Acute Oligoanuric Renal Failure in Dextran 40 Treated Patients with Acute Ischemic Stroke Stage III or IV

Abstract: Two hundred eleven patients with acute ischemic stroke, stage III or IV, received daily intravenous infusion of 500-1000 mL low-molecular dextran (dextran 40) over a period of 4 days. In 10 cases (4.7%) acute renal failure, associated with dextran infusion, could be observed; oligoanuria occurred after a mean time of 4 (3-6) days. The incidence of dextran-induced acute renal failure was significantly higher in patients with a preexisting reduction of glomerular filtration rate below 30 mL/min/1.73 m2 (p < 0.00… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
22
0

Year Published

1998
1998
2017
2017

Publication Types

Select...
3
3
1

Relationship

0
7

Authors

Journals

citations
Cited by 40 publications
(22 citation statements)
references
References 10 publications
0
22
0
Order By: Relevance
“…Case reports have described more than 60 patients developing ARF attributable to dextran 40 administration [70][71][72]74,76,79,83,84,87,[90][91][92]95]. ARF associated with dextran 40 infusion was encountered in 4.7% out of 211 acute ischaemic stroke patients [63]. Plasmapheresis may be necessary to remove the dextran load [74,79,83,90,91,95].…”
Section: Dextranmentioning
confidence: 98%
See 1 more Smart Citation
“…Case reports have described more than 60 patients developing ARF attributable to dextran 40 administration [70][71][72]74,76,79,83,84,87,[90][91][92]95]. ARF associated with dextran 40 infusion was encountered in 4.7% out of 211 acute ischaemic stroke patients [63]. Plasmapheresis may be necessary to remove the dextran load [74,79,83,90,91,95].…”
Section: Dextranmentioning
confidence: 98%
“…A total of 92 studies were included in the review: 23 randomized clinical trials [6,11,12,15,17,[19][20][21][22][23][24][25][26][27][28][29][30][31][32][33][34][35][36]; 17 non-randomized controlled clinical studies [37][38][39][40][41][42][43][44][45][46][47][48][49][50][51][52][53]; 16 non-controlled cohort clinical studies [54][55][56][57][58][59][60][61][62][63][64]…”
Section: Included Studiesmentioning
confidence: 99%
“…Several small studies have described oligo-anuric AKI with infusion of low molecular weight dextrans [29,[36][37][38]. HES has also been described to cause AKI, [14,39].…”
Section: Synthetic Colloidal Plasma Substitutesmentioning
confidence: 99%
“…For example, these colloids are associated with increased rates of anaphylactoid reactions and prolonged pruritus [28]. In addition, these synthetic colloids can lead to coagulopathy and kidney injury [14,27,[29][30][31][32][33]. Impaired hemostasis has been attributed to hemodilution and to a direct effect on platelet function, coagulation factors (i.e.…”
Section: Synthetic Colloidal Plasma Substitutesmentioning
confidence: 99%
“…89 In a cohort study of patients with acute ischemic stroke, 4.7% experienced acute renal failure associated with dextran infusion. 72 Gelatin, as compared with albumin as pump prime in cardiac surgery, elevated creatinine levels. …”
Section: Renal Failurementioning
confidence: 99%